Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $98.50M in the twelve months ending December 31, 2023, down -6.71% year-over-year. Revenue in the quarter ending December 31, 2023 was $22.93M, a -12.73% decrease year-over-year. In the fiscal year ending June 30, 2023, Aytu BioPharma had annual revenue of $107.40M with 11.10% growth.

• Revenue (ttm): $98.50M
• Revenue Growth: -6.71%
• P/S Ratio: 0.16
• Revenue / Employee: $656,653
• Employees: 150
• Market Cap: 16.17M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	107.40M	10.73M	11.10%
Jun 30, 2022	96.67M	31.04M	47.29%
Jun 30, 2021	65.63M	38.00M	137.52%
Jun 30, 2020	27.63M	20.31M	277.47%
Jun 30, 2019	7.32M	3.66M	100.00%
Jun 30, 2018	3.66M	438.53K	13.61%
Jun 30, 2017	3.22M	659.15K	25.72%
Jun 30, 2016	2.56M	2.30M	878.85%
Jun 30, 2015	261.78K	202.85K	344.23%
Jun 30, 2014	58.93K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.